Nu Skin Enterprises (NUS) 10-Q 5 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 01, 2020
Cover [Abstract]
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-12421
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,030,963

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 366,710	$ 335,630
Current investments	11,301	8,413
Accounts receivable, net	60,016	50,378
Inventories, net	270,319	275,891
Prepaid expenses and other	63,916	69,854
Total current assets	772,262	740,166
Property and equipment, net	456,083	453,604
Right-of-use assets	165,749	144,326
Goodwill	196,573	196,573
Other intangible assets, net	74,391	80,321
Other assets	151,653	154,016
Total assets	1,816,711	1,769,006
Current liabilities:
Accounts payable	55,298	38,979
Accrued expenses	381,052	290,281
Current portion of long-term debt	30,000	27,500
Total current liabilities	466,350	356,760
Operating lease liabilities	121,439	105,701
Long-term debt	312,664	334,461
Other liabilities	88,785	96,795
Total liabilities	989,238	893,717
Commitments and contingencies (Note 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	570,491	557,544
Treasury stock, at cost - 39.5 million and 35.0 million shares	(1,446,374)	(1,324,826)
Accumulated other comprehensive loss	(83,108)	(85,292)
Retained earnings	1,786,373	1,727,772
Total stockholders' equity	827,473	875,289
Total liabilities and stockholders' equity	$ 1,816,711	$ 1,769,006

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2020	Dec. 31, 2019
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	39.5	35

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 703,347	$ 589,934	$ 1,833,741	$ 1,837,057
Cost of sales	183,374	140,162	463,277	440,854
Gross profit	519,973	449,772	1,370,464	1,396,203
Operating expenses:
Selling expenses	280,695	231,937	735,365	727,473
General and administrative expenses	165,050	147,943	466,232	455,983
Total operating expenses	445,745	379,880	1,201,597	1,183,456
Operating income	74,228	69,892	168,867	212,747
Other income (expense), net	525	(4,979)	(4,068)	(11,153)
Income before provision for income taxes	74,753	64,913	164,799	201,594
Provision for income taxes	18,446	20,823	46,911	68,153
Net income	$ 56,307	$ 44,090	$ 117,888	$ 133,441
Net income per share (Note 6):
Basic (in dollars per share)	$ 1.10	$ 0.79	$ 2.24	$ 2.40
Diluted (in dollars per share)	$ 1.08	$ 0.79	$ 2.23	$ 2.39
Weighted-average common shares outstanding:
Basic (in shares)	51,308	55,548	52,741	55,507
Diluted (in shares)	52,243	55,788	52,906	55,950

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 56,307	$ 44,090	$ 117,888	$ 133,441
Other comprehensive income, net of tax:
Foreign currency translation adjustment, net of taxes of $(8) and $(31) for the three months ended September 30, 2020 and 2019, respectively, and $(3) and $186 for the nine months ended September 30, 2020 and 2019, respectively	10,022	(13,685)	1,873	(15,027)
Net unrealized gains/(losses) on cash flow hedge, net of tax benefit of $(83) and zero for the three months ended September 30, 2020 and 2019, respectively and $(83) and zero for the nine months ended September 30, 2020 and 2019, respectively.	305	0	305	0
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedge, net of taxes of $(2) and zero for the three months ended September 30, 2020 and 2019, respectively and $(2) and zero for the nine months ended September 30, 2020 and 2019, respectively	6	0	6	0
Other comprehensive income, net of tax	10,333	(13,685)	2,184	(15,027)
Comprehensive income	$ 66,640	$ 30,405	$ 120,072	$ 118,414

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ (8)	$ (31)	$ (3)	$ 186
Net unrealized gains/(losses) on cash flow hedge, tax	(83)	0	(83)	0
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedge, tax	$ (2)	$ 0	$ (2)	$ 0

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total	Cumulative Effect Adjustment [Member]Common Stock [Member]Class A [Member]	Cumulative Effect Adjustment [Member]Additional Paid-in Capital [Member]	Cumulative Effect Adjustment [Member]Treasury Stock [Member]	Cumulative Effect Adjustment [Member]Accumulated Other Comprehensive Loss [Member]	Cumulative Effect Adjustment [Member]Retained Earnings [Member]	Cumulative Effect Adjustment [Member]
Balance at beginning of period at Dec. 31, 2018	$ 91	$ 552,564	$ (1,326,605)	$ (79,934)	$ 1,635,751	$ 781,867
Balance at beginning of period (ASC 842 [Member]) at Dec. 31, 2018							$ 0	$ 0	$ 0	$ 0	$ 657	$ 657
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	133,441	133,441
Other comprehensive (loss) income, net of tax	0	0	0	(15,027)	0	(15,027)
Repurchase of Class A common stock (Note 6)	0	0	(825)	0	0	(825)
Exercise of employee stock options/vesting of stock awards	0	(4,930)	2,604	0	0	(2,326)
Stock-based compensation	0	9,649	0	0	0	9,649
Cash dividends	0	0	0	0	(61,636)	(61,636)
Balance at end of period at Sep. 30, 2019	91	557,283	(1,324,826)	(94,961)	1,708,213	845,800
Balance at beginning of period at Jun. 30, 2019	91	556,294	(1,324,834)	(81,276)	1,684,675	834,950
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	44,090	44,090
Other comprehensive (loss) income, net of tax	0	0	0	(13,685)	0	(13,685)
Repurchase of Class A common stock (Note 6)	0	0	0	0	0	0
Exercise of employee stock options/vesting of stock awards	0	(26)	8	0	0	(18)
Stock-based compensation	0	1,015	0	0	0	1,015
Cash dividends	0	0	0	0	(20,552)	(20,552)
Balance at end of period at Sep. 30, 2019	91	557,283	(1,324,826)	(94,961)	1,708,213	845,800
Balance at beginning of period at Dec. 31, 2019	91	557,544	(1,324,826)	(85,292)	1,727,772	875,289
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	117,888	117,888
Other comprehensive (loss) income, net of tax	0	0	0	2,184	0	2,184
Repurchase of Class A common stock (Note 6)	0	0	(127,361)	0	0	(127,361)
Exercise of employee stock options/vesting of stock awards	0	(2,492)	5,813	0	0	3,321
Stock-based compensation	0	15,439	0	0	0	15,439
Cash dividends	0	0	0	0	(59,287)	(59,287)
Balance at end of period at Sep. 30, 2020	91	570,491	(1,446,374)	(83,108)	1,786,373	827,473
Balance at beginning of period at Jun. 30, 2020	91	563,115	(1,427,064)	(93,441)	1,749,311	792,012
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	56,307	56,307
Other comprehensive (loss) income, net of tax	0	0	0	10,333	0	10,333
Repurchase of Class A common stock (Note 6)	0	0	(19,994)	0	0	(19,994)
Exercise of employee stock options/vesting of stock awards	0	261	684	0	0	945
Stock-based compensation	0	7,115	0	0	0	7,115
Cash dividends	0	0	0	0	(19,245)	(19,245)
Balance at end of period at Sep. 30, 2020	$ 91	$ 570,491	$ (1,446,374)	$ (83,108)	$ 1,786,373	$ 827,473

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0	0	0.3	0.2

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 117,888	$ 133,441
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	55,279	57,964
Non-cash lease expense	34,087	33,494
Stock-based compensation	15,439	9,649
Foreign currency losses	1,203	4,145
Loss on disposal of assets	2,516	0
Deferred taxes	(7,931)	1,945
Changes in operating assets and liabilities:
Accounts receivable	(9,273)	(3,981)
Inventories, net	4,882	6,775
Prepaid expenses and other	4,180	(21,097)
Other assets	(76,487)	(27,101)
Accounts payable	15,884	(6,609)
Accrued expenses	99,438	(62,679)
Other liabilities	27,343	2,082
Net cash provided by operating activities	284,448	128,028
Cash flows from investing activities:
Purchases of property and equipment	(48,810)	(52,784)
Proceeds on investment sales	7,630	11,160
Purchases of investments	(8,759)	(8,432)
Acquisitions and investments in equity investees	0	(8,073)
Net cash used in investing activities	(49,939)	(58,129)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	3,321	(2,326)
Payment of cash dividends	(59,287)	(61,636)
Repurchases of shares of common stock	(127,361)	(825)
Payments of debt	(135,000)	(209,455)
Proceeds from debt	115,000	145,000
Net cash used in financing activities	(203,327)	(129,242)
Effect of exchange rate changes on cash	(102)	(7,534)
Net increase (decrease) in cash and cash equivalents	31,080	(66,877)
Cash and cash equivalents, beginning of period	335,630	386,911
Cash and cash equivalents, end of period	$ 366,710	$ 320,034

The Company

The Company	9 Months Ended
	Sep. 30, 2020
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, a leading global direct selling company, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from segments, consisting of its geographic Nu Skin segments — Mainland China; South Korea; Southeast Asia, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand and Vietnam; Americas/Pacific, which includes Australia, Canada, Latin America, New Zealand and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa (“EMEA”), which includes several markets in Europe as well as Israel, Russia and South Africa —its Manufacturing segment, which includes manufacturing and packaging subsidiaries; and its (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. Additionally, based on the duration and severity of the novel coronavirus (“COVID-19”) pandemic, including but not limited to limitations of holding sales meetings, supply chain disruptions, reduced travel and closed walk-in locations, the Company remains uncertain of the ultimate impact COVID-19 could have on the business. To date, the pandemic has not increased the Company’s costs of or access to capital under the revolving credit facility, and at this time the Company cannot provide assurance it will not in the future. This uncertainty could have an impact in future periods on certain estimates used in the preparation of the third quarter financial results, including, but not limited to, impairment of goodwill and other long-lived assets, income tax provision and recoverability of inventory. Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This guidance modifies the measurement of expected credit losses of certain financial instruments. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods and should be applied on a modified retrospective basis to all periods presented. This ASU was effective for the Company beginning on January 1, 2020. The adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract his ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In March the FASB issued, ASU - Reference Rate Reform (Topic 848) : Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited time to ease the potential burden in accounting for the effects of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU - applies only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December The amendments in ASU - are elective and are effective upon issuance for all entities. The Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur. Inventory Inventories consist of the following (U.S. dollars in thousands): September 30, 2020 December 31, 2019 Raw materials $ 92,911 $ 87,942 Finished goods 177,408 187,949 Total Inventory, net $ 270,319 $ 275,891 Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of September 30, 2020 and December 31, 2019 was $ million and $ million, respectively. Derivative instruments and hedging activities FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments. As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2020
Goodwill [Abstract]
Goodwill	3. Goodwill The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2020 and December 31, 2019 (U.S. dollars in thousands): September 30, 2020 December 31, 2019 Nu Skin Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt [Abstract]
Debt	4. Debt Credit Agreement On April 18, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides for a $ million term loan facility and a $ million revolving credit facility, each with a term of . Both facilities bear interest at the London Interbank Offered Rate (“LIBOR”), plus a margin based on the consolidated leverage ratio. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of during the first and second years, during the third and fourth years and during the fifth year after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding to 1.00 and a consolidated interest coverage ratio of no less than to 1.00. As of 30, 2020, the Company was in compliance with all covenants under the Credit Agreement. The following table summarizes the Company’s debt facilities as of 30, 2020 and December 31, 2019: Facility or Arrangement Original Principal Amount Balance as of September 30 , 2020 (1)(2) Balance as of December 31, 2019 (2) Interest Rate Repayment Terms Credit Agreement term loan facility $ 400.0 million $ 345.0 million $ 365.0 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $ — $ — Variable Revolving line of credit expires April 18, 2023. (1) As of 30, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $ million of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $ million and $ million as of 30, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases

Leases	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Leases	5. Leases The Company has operating and finance leases for regional offices, manufacturing facilities, retail centers, distribution centers and certain equipment. The Company’s leases have remaining lease terms of 1 year to 24 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 1 year. As of 30, 2020, the weighted average remaining lease term and weighted average discount rate for operating leases was years and . The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating lease cost $ 13,038 $ 12,399 $ 39,043 $ 37,677 Variable lease cost 678 732 2,062 2,889 Short-term lease cost 118 41 258 145 Sublease income (1,075 ) (1,395 ) (3,264 ) (4,563 ) Total lease expense $ 12,759 $ 11,777 $ 38,099 $ 36,148 Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Nine Months Ended September 30, 2020 2019 Operating cash outflow from operating leases $ 40,865 $ 39,885 Right-of-use assets obtained in exchange for lease obligations $ 62,514 $ 150,127 Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases 2020 $ 15,631 2021 53,303 2022 36,529 2023 26,418 2024 21,389 Thereafter 41,468 Total 194,738 Less: Finance charges 26,820 Total principal liability $ 167,918 During the third quarter of 2020, the Company recognized $31.3 million of right-of-use assets, primarily in connection with building and warehouse lease renewals. The Company has additional lease liabilities of $ million which have not yet commenced as of 30, 2020, and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2020
Capital Stock [Abstract]
Capital Stock	6. Capital Stock Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended 30, 2020 and 2019, stock options of million and million, respectively, and for the -month periods ended 30, 2020 and 2019, stock options of million and million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends In February , April July 2020 , the Company’s board of directors declared quarterly cash dividends of $ per share. These quarterly cash dividends of $ million were paid on to stockholders of record on . October 2020 Repurchase of common stock During the three-month periods ended 30, 2020 and 2019, the Company repurchased of its Class A common stock under its stock repurchase plan for $ million and , respectively. During the -month periods ended 30, 2020 and 2019, the Company repurchased million shares and shares of its Class A common stock under its stock repurchase plan for $ million and $ million, respectively. As of 30, 2020, $ million was available for repurchases under the Company’s stock repurchase plan.

Fair Value

Fair Value	9 Months Ended
	Sep. 30, 2020
Fair Value [Abstract]
Fair Value	7. Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximates fair values due to the short-term nature of these instruments. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ◾ Level 1 – quoted prices in active markets for identical assets or liabilities; ◾ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ◾ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2020 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 45,552 $ — $ — $ 45,552 Other long-term assets 1,344 — — 1,344 Derivative financial instruments asset — 472 — 472 Life insurance contracts — — 41,328 41,328 Derivative financial instruments liability — (76 ) — (76 ) Total $ 46,896 $ 396 $ 41,328 $ 88,620 Fair Value at December 31, 2019 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 54,642 $ — $ — $ 54,642 Other long-term assets 3,216 — — 3,216 Life insurance contracts — — 41,707 41,707 Total $ 57,858 $ — $ 41,707 $ 99,565 See Note 9 - Derivatives and Hedging Activities, for more information on derivative financial instruments. The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2020 $ 41,707 Actual return on plan assets (379 ) Purchase and issuances — Sales and settlements — Transfers into Level 3 — Ending balance at September 30, 2020 $ 41,328

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2020
Income Taxes [Abstract]
Income Taxes	8. Income Taxes Provision for income taxes for the three- and -month periods of 2020 was $ million and $ million, compared to $ million and $ million for the prior-year periods. The effective tax rates for the three- and -month periods were and of pre-tax income compared to and in the prior-year periods. The Company accounts for income taxes in accordance with ASC Topic These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $ million and $ million as of 30, 2020 and December 31, 2019, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. For all foreign earnings, the Company accrues the applicable foreign income taxes. For the earnings that have been indefinitely reinvested, the Company does not accrue foreign withholding taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no foreign withholding taxes have been provided, aggregate to $60.0 million as of December 31, 2019. If the amount designated as indefinitely reinvested as of December 31, 2019 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company intends to utilize the indefinitely reinvested offshore earnings to fund foreign investments, specifically capital expenditures. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2019. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2016. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in CAP for 2020 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2012. However, statutes of limitations in certain countries may be as long as . The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitations, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments,

Derivatives and Hedging Activit

Derivatives and Hedging Activities	9 Months Ended
	Sep. 30, 2020
Derivatives and Hedging Activities
Derivatives and Hedging Activities	9. Derivatives and Hedging Activities Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2020, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $76 thousand will be reclassified as an increase to interest expense. As of September 30, 2020, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location September 30, 2020 December 31, 2019 Interest Rate Swap - Asset Other Assets $ 472 $ — Interest Rate Swap - Liability Accrued Expenses $ 76 $ — Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain or (Loss) Recognized in OCI on Derivative Three Months Ended Nine Months Ended Derivatives in Cash flow September 30, September 30, Hedging Relationships: 2020 2019 2020 2019 Interest Rate Swaps $ 396 $ — $ 396 $ — Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended Derivatives in Cash flow Income Statement September 30, September 30, Hedging Relationships: Location 2020 2019 2020 2019 Interest Rate Swaps Other Income $ (8) $ — $ (8) $ —

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2020
Segment Information [Abstract]
Segment Information	10. Segment Information The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Mainland China, Americas/Pacific, South Korea, Southeast Asia, Japan, EMEA, and Hong Kong/Taiwan—and its Manufacturing and Grow Tech segments. The Other category includes miscellaneous corporate revenue and related adjustments. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 169,068 $ 173,974 $ 453,096 $ 567,795 Americas/Pacific 151,465 83,635 353,957 262,932 South Korea 83,460 79,435 236,094 248,020 Southeast Asia 84,102 78,963 220,517 226,853 Japan 70,958 67,197 200,549 194,557 EMEA 61,411 35,742 147,590 120,960 Hong Kong/Taiwan 42,265 40,449 115,253 124,719 Other (314 ) (62 ) 374 (239 ) Total Nu Skin 662,415 559,333 1,727,430 1,745,597 Manufacturing (1) 40,910 30,601 105,975 91,430 Grow Tech 22 — 336 30 Total $ 703,347 $ 589,934 $ 1,833,741 $ 1,837,057 (1) The Manufacturing segment had $ million and $ million of intersegment revenue for the months ended and , respectively, and $ million and $ million for the months ended and , respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above. Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 54,522 $ 48,619 $ 135,577 $ 158,873 Americas/Pacific 26,256 12,875 61,184 41,314 South Korea 25,232 24,770 73,421 76,417 Southeast Asia 20,426 22,063 54,121 60,895 Japan 18,245 16,287 49,292 46,216 EMEA 7,111 1,529 11,084 6,114 Hong Kong/Taiwan 9,048 8,063 22,825 24,754 Nu Skin contribution 160,840 134,206 407,504 414,583 Manufacturing 6,749 4,577 15,000 11,598 Grow Tech (5,322 ) (5,822 ) (17,659 ) (14,033 ) Total segment contribution 162,267 132,961 404,845 412,148 Corporate and other (88,039 ) (63,069 ) (235,978 ) (199,401 ) Operating income 74,228 69,892 168,867 212,747 Other income (expense) 525 (4,979 ) (4,068 ) (11,153 ) Income before provision for income taxes $ 74,753 $ 64,913 $ 164,799 $ 201,594 Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 2,649 $ 2,708 $ 7,631 $ 8,733 Americas/Pacific 268 213 766 633 South Korea 756 1,115 2,731 3,997 Southeast Asia 317 434 1,248 1,373 Japan 296 938 1,602 2,943 EMEA 231 268 731 980 Hong Kong/Taiwan 691 547 1,948 1,600 Total Nu Skin 5,208 6,223 16,657 20,259 Manufacturing 2,077 1,711 5,954 4,916 Grow Tech 1,302 1,244 3,775 3,064 Corporate and other 9,333 10,127 28,893 29,725 Total $ 17,920 $ 19,305 $ 55,279 $ 57,964 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 9,000 $ 10,614 $ 12,577 $ 13,328 Americas/Pacific 125 337 891 1,084 South Korea 173 972 537 1,051 Southeast Asia 1,254 140 1,893 459 Japan 1,484 267 3,132 1,385 EMEA 718 16 1,378 92 Hong Kong/Taiwan 7 99 23 1,653 Total Nu Skin 12,761 12,445 20,431 19,052 Manufacturing 2,113 1,100 13,221 4,281 Grow Tech 343 2,577 760 7,628 Corporate and other 4,901 7,448 14,398 21,823 Total $ 20,118 $ 23,570 $ 48,810 $ 52,784

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2020
Restructuring [Abstract]
Restructuring	12. Restructuring In the quarter of , the Company began a strategic plan to align its resources and capabilities to support its vision of being a world-leading business platform. This program primarily impacted the Company’s information technology infrastructure and organization and other departments within its corporate and Americas offices. As a result of the restructuring program, the Company recorded a non-cash charge of $ million for impairment of information technology assets, including internally developed software for social sharing and digital initiatives, and $ million of cash charges, including $ million for employee severance and $ million for other related cash charges with the restructuring. The restructuring charges were predominately recorded in the Corporate and Other category. See the table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ — There was no restructuring activity for the three or nine months ended September 30, 2020 and three months ended September 30, 2019.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements.
Consolidation	The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
Accounting Pronouncements	Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This guidance modifies the measurement of expected credit losses of certain financial instruments. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods and should be applied on a modified retrospective basis to all periods presented. This ASU was effective for the Company beginning on January 1, 2020. The adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract his ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In March the FASB issued, ASU - Reference Rate Reform (Topic 848) : Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited time to ease the potential burden in accounting for the effects of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU - applies only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December The amendments in ASU - are elective and are effective upon issuance for all entities. The Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.
Inventory	Inventory Inventories consist of the following (U.S. dollars in thousands): September 30, 2020 December 31, 2019 Raw materials $ 92,911 $ 87,942 Finished goods 177,408 187,949 Total Inventory, net $ 270,319 $ 275,891
Revenue Recognition	Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of September 30, 2020 and December 31, 2019 was $ million and $ million, respectively.
Derivative Instruments and Hedging Activities	Derivative instruments and hedging activities FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments. As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): September 30, 2020 December 31, 2019 Raw materials $ 92,911 $ 87,942 Finished goods 177,408 187,949 Total Inventory, net $ 270,319 $ 275,891

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2020 and December 31, 2019 (U.S. dollars in thousands): September 30, 2020 December 31, 2019 Nu Skin Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of 30, 2020 and December 31, 2019: Facility or Arrangement Original Principal Amount Balance as of September 30 , 2020 (1)(2) Balance as of December 31, 2019 (2) Interest Rate Repayment Terms Credit Agreement term loan facility $ 400.0 million $ 345.0 million $ 365.0 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $ — $ — Variable Revolving line of credit expires April 18, 2023. (1) As of 30, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $ million of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $ million and $ million as of 30, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating lease cost $ 13,038 $ 12,399 $ 39,043 $ 37,677 Variable lease cost 678 732 2,062 2,889 Short-term lease cost 118 41 258 145 Sublease income (1,075 ) (1,395 ) (3,264 ) (4,563 ) Total lease expense $ 12,759 $ 11,777 $ 38,099 $ 36,148
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Nine Months Ended September 30, 2020 2019 Operating cash outflow from operating leases $ 40,865 $ 39,885 Right-of-use assets obtained in exchange for lease obligations $ 62,514 $ 150,127
Maturities of Operating Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases 2020 $ 15,631 2021 53,303 2022 36,529 2023 26,418 2024 21,389 Thereafter 41,468 Total 194,738 Less: Finance charges 26,820 Total principal liability $ 167,918

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value [Abstract]
Assets Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2020 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 45,552 $ — $ — $ 45,552 Other long-term assets 1,344 — — 1,344 Derivative financial instruments asset — 472 — 472 Life insurance contracts — — 41,328 41,328 Derivative financial instruments liability — (76 ) — (76 ) Total $ 46,896 $ 396 $ 41,328 $ 88,620 Fair Value at December 31, 2019 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 54,642 $ — $ — $ 54,642 Other long-term assets 3,216 — — 3,216 Life insurance contracts — — 41,707 41,707 Total $ 57,858 $ — $ 41,707 $ 99,565
Changes in Fair Value of Level 3 Marketable Securities	The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2020 $ 41,707 Actual return on plan assets (379 ) Purchase and issuances — Sales and settlements — Transfers into Level 3 — Ending balance at September 30, 2020 $ 41,328

Derivatives and Hedging Activ_2

Derivatives and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2020
Derivatives and Hedging Activities
Fair Values of Derivative Instruments on the Balance Sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location September 30, 2020 December 31, 2019 Interest Rate Swap - Asset Other Assets $ 472 $ — Interest Rate Swap - Liability Accrued Expenses $ 76 $ —
Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income	The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain or (Loss) Recognized in OCI on Derivative Three Months Ended Nine Months Ended Derivatives in Cash flow September 30, September 30, Hedging Relationships: 2020 2019 2020 2019 Interest Rate Swaps $ 396 $ — $ 396 $ — Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended Derivatives in Cash flow Income Statement September 30, September 30, Hedging Relationships: Location 2020 2019 2020 2019 Interest Rate Swaps Other Income $ (8) $ — $ (8) $ —

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 169,068 $ 173,974 $ 453,096 $ 567,795 Americas/Pacific 151,465 83,635 353,957 262,932 South Korea 83,460 79,435 236,094 248,020 Southeast Asia 84,102 78,963 220,517 226,853 Japan 70,958 67,197 200,549 194,557 EMEA 61,411 35,742 147,590 120,960 Hong Kong/Taiwan 42,265 40,449 115,253 124,719 Other (314 ) (62 ) 374 (239 ) Total Nu Skin 662,415 559,333 1,727,430 1,745,597 Manufacturing (1) 40,910 30,601 105,975 91,430 Grow Tech 22 — 336 30 Total $ 703,347 $ 589,934 $ 1,833,741 $ 1,837,057 (1) The Manufacturing segment had $ million and $ million of intersegment revenue for the months ended and , respectively, and $ million and $ million for the months ended and , respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.
Segment Contribution	Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 54,522 $ 48,619 $ 135,577 $ 158,873 Americas/Pacific 26,256 12,875 61,184 41,314 South Korea 25,232 24,770 73,421 76,417 Southeast Asia 20,426 22,063 54,121 60,895 Japan 18,245 16,287 49,292 46,216 EMEA 7,111 1,529 11,084 6,114 Hong Kong/Taiwan 9,048 8,063 22,825 24,754 Nu Skin contribution 160,840 134,206 407,504 414,583 Manufacturing 6,749 4,577 15,000 11,598 Grow Tech (5,322 ) (5,822 ) (17,659 ) (14,033 ) Total segment contribution 162,267 132,961 404,845 412,148 Corporate and other (88,039 ) (63,069 ) (235,978 ) (199,401 ) Operating income 74,228 69,892 168,867 212,747 Other income (expense) 525 (4,979 ) (4,068 ) (11,153 ) Income before provision for income taxes $ 74,753 $ 64,913 $ 164,799 $ 201,594
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 2,649 $ 2,708 $ 7,631 $ 8,733 Americas/Pacific 268 213 766 633 South Korea 756 1,115 2,731 3,997 Southeast Asia 317 434 1,248 1,373 Japan 296 938 1,602 2,943 EMEA 231 268 731 980 Hong Kong/Taiwan 691 547 1,948 1,600 Total Nu Skin 5,208 6,223 16,657 20,259 Manufacturing 2,077 1,711 5,954 4,916 Grow Tech 1,302 1,244 3,775 3,064 Corporate and other 9,333 10,127 28,893 29,725 Total $ 17,920 $ 19,305 $ 55,279 $ 57,964 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2020 2019 2020 2019 Nu Skin Mainland China $ 9,000 $ 10,614 $ 12,577 $ 13,328 Americas/Pacific 125 337 891 1,084 South Korea 173 972 537 1,051 Southeast Asia 1,254 140 1,893 459 Japan 1,484 267 3,132 1,385 EMEA 718 16 1,378 92 Hong Kong/Taiwan 7 99 23 1,653 Total Nu Skin 12,761 12,445 20,431 19,052 Manufacturing 2,113 1,100 13,221 4,281 Grow Tech 343 2,577 760 7,628 Corporate and other 4,901 7,448 14,398 21,823 Total $ 20,118 $ 23,570 $ 48,810 $ 52,784

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2020
Restructuring [Abstract]
Restructuring Activity	See the table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ —

The Company (Details)

The Company (Details)	9 Months Ended
	Sep. 30, 2020Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventories [Abstract]
Raw materials	$ 92,911	$ 87,942
Finished goods	177,408	187,949
Total Inventory, net	$ 270,319	$ 275,891

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 17.8		$ 17.8		$ 12.5
Contract liabilities impact to revenue	$ (1.8)	$ 0	$ (5.3)	$ 1.1

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Goodwill [Abstract]
Goodwill	$ 196,573	$ 196,573
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Americas/Pacific [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Southeast Asia [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	72,469	72,469
Grow Tech [Member]
Goodwill [Abstract]
Goodwill	$ 9,150	$ 9,150

Debt, Credit Agreement (Details

Debt, Credit Agreement (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Apr. 18, 2018
Credit Agreement [Member] | Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
Credit Agreement [Member] | Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
Term Loan Facility [Member] | First Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Third Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	10.00%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 350
Term of loan	5 years

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2020		Dec. 31, 2019	Apr. 18, 2018
Debt [Abstract]
Current portion of long-term debt		$ 30,000		$ 27,500
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs		2,300		3,000
Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		400,000			$ 400,000
Balance	[2]	$ 345,000	[1]	365,000
Interest rate		Variable 30 day: 2.40%
Interest rate		2.40%
Term of variable rate		30 days
Repayment terms		35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments		35.00%
Term of loan		5 years
Current portion of long-term debt		$ 30,000
Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	[2]	$ 0	[1]	$ 0
Interest rate		Variable 30 day: —
Interest rate		0.00%
Term of variable rate		30 days
Repayment terms		Revolving line of credit expires April 18, 2023.
Term of loan		5 years
[1]	As of September 30, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $30.0 million of the balance of its term loan under the Credit Agreement.
[2]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.3 million and $3.0 million as of September 30, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Weighted average remaining lease term for operating leases	6 years 3 months 18 days		6 years 3 months 18 days
Weighted average discount rate for operating leases	4.30%		4.30%
Components of Lease Expense [Abstract]
Operating lease cost	$ 13,038	$ 12,399	$ 39,043	$ 37,677
Variable lease cost	678	732	2,062	2,889
Short-term lease cost	118	41	258	145
Sublease income	(1,075)	(1,395)	(3,264)	(4,563)
Total lease expense	12,759	$ 11,777	38,099	36,148
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases			40,865	39,885
Right-of-use assets obtained in exchange for lease liabilities			62,514	$ 150,127
Maturities of Operating Lease Liabilities [Abstract]
2020	15,631		15,631
2021	53,303		53,303
2022	36,529		36,529
2023	26,418		26,418
2024	21,389		21,389
Thereafter	41,468		41,468
Total	194,738		194,738
Less: Finance charges	26,820		26,820
Total principal liability	167,918		167,918
Right-of-use assets recognized	31,300
Additional lease liabilities not yet commenced	$ 1,200		$ 1,200
Minimum [Member]
Leases [Abstract]
Remaining lease terms			1 year
Maximum [Member]
Leases [Abstract]
Remaining lease terms			24 years
Extension period for leases			20 years
Termination period for leases			1 year

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 09, 2020	Jun. 10, 2020	Mar. 11, 2020	Oct. 30, 2020	Jul. 31, 2020	Apr. 30, 2020	Feb. 29, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Dividends per Share [Abstract]
Payment of cash dividends										$ 59,287	$ 61,636
Repurchases of Common Stock [Abstract]
Class A common stock repurchased								$ 19,994	$ 0	127,361	$ 825
Amount available for repurchases								$ 342,800		$ 342,800
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)								400,000	0	4,800,000	14,000
Class A common stock repurchased								$ 19,994	$ 0	$ 127,361	$ 825
Dividend Declared 2020-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2020-02		2020-02
Dividend payable per share (in dollars per share)							$ 0.375
Payment of cash dividends			$ 20,700
Dividend payable, date paid										Mar. 11, 2020
Dividend payable, date of record										Feb. 28, 2020
Dividend Declared 2020-Q2 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2020-04		2020-04
Dividend payable per share (in dollars per share)						$ 0.375
Payment of cash dividends		$ 19,400
Dividend payable, date paid										Jun. 10, 2020
Dividend payable, date of record										May 29, 2020
Dividend Declared 2020-Q3 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2020-07		2020-07
Dividend payable per share (in dollars per share)					$ 0.375
Payment of cash dividends	$ 19,200
Dividend payable, date paid										Sep. 9, 2020
Dividend payable, date of record										Aug. 28, 2020
Dividend Declared 2020-Q4 [Member] | Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2020-10
Dividend payable per share (in dollars per share)				$ 0.375
Dividend payable, date paid				Dec. 9, 2020
Dividend payable, date of record				Nov. 27, 2020
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)								200,000	1,300,000	600,000	1,200,000

Fair Value (Details)

Fair Value (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	$ 45,552	$ 54,642
Other long-term assets	1,344	3,216
Derivative financial instruments asset	472
Life insurance contracts	41,328	41,707
Derivative financial instruments liability	(76)
Financial assets (liabilities)	88,620	99,565
Fair Value on a Recurring Basis [Member] | Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	45,552	54,642
Other long-term assets	1,344	3,216
Derivative financial instruments asset	0
Life insurance contracts	0	0
Derivative financial instruments liability	0
Financial assets (liabilities)	46,896	57,858
Fair Value on a Recurring Basis [Member] | Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Derivative financial instruments asset	472
Life insurance contracts	0	0
Derivative financial instruments liability	(76)
Financial assets (liabilities)	396	0
Fair Value on a Recurring Basis [Member] | Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Derivative financial instruments asset	0
Life insurance contracts	41,328	41,707
Derivative financial instruments liability	0
Financial assets (liabilities)	41,328	$ 41,707
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	41,707
Actual return on plan assets	(379)
Purchases and issuances	0
Sales and settlements	0
Transfers into Level 3	0
Ending balance	$ 41,328

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Income Taxes [Abstract]
Provision for income taxes	$ 18,446	$ 20,823	$ 46,911	$ 68,153
Effective tax rate	24.70%	32.10%	28.50%	33.80%
Net deferred tax assets	$ 27,100		$ 27,100		$ 20,000
Undistributed earnings of non-U.S. subsidiaries					60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated					$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	(100)		$ (100)
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations			10 years
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ (1,000)		$ (1,000)

Derivatives and Hedging Activ_3

Derivatives and Hedging Activities, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)Derivatives	Dec. 31, 2019USD ($)
Derivatives and Hedging Activities [Abstract]
Gain to be reclassified to interest expense during next twelve months	$ 76
Number of outstanding derivatives held | Derivatives	4
Notional amount	$ 200,000
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	472	$ 0
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Accrued Expenses [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, liability	$ 76	$ 0

Derivatives and Hedging Activ_4

Derivatives and Hedging Activities, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Other Income [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ (8)	$ 0	$ (8)	$ 0
Other Comprehensive Loss [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ 396	$ 0	$ 396	$ 0

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)Segment	Sep. 30, 2019USD ($)
Segment Information [Abstract]
Number of reportable segments | Segment				9
Number of geographic segments | Segment				7
Revenue by Segment [Abstract]
Revenue		$ 703,347	$ 589,934	$ 1,833,741	$ 1,837,057
Other [Member]
Revenue by Segment [Abstract]
Revenue		(314)	(62)	374	(239)
Operating Segment [Member] | Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		662,415	559,333	1,727,430	1,745,597
Operating Segment [Member] | Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		169,068	173,974	453,096	567,795
Operating Segment [Member] | Americas/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		151,465	83,635	353,957	262,932
Operating Segment [Member] | South Korea [Member]
Revenue by Segment [Abstract]
Revenue		83,460	79,435	236,094	248,020
Operating Segment [Member] | Southeast Asia [Member]
Revenue by Segment [Abstract]
Revenue		84,102	78,963	220,517	226,853
Operating Segment [Member] | Japan [Member]
Revenue by Segment [Abstract]
Revenue		70,958	67,197	200,549	194,557
Operating Segment [Member] | EMEA [Member]
Revenue by Segment [Abstract]
Revenue		61,411	35,742	147,590	120,960
Operating Segment [Member] | Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		42,265	40,449	115,253	124,719
Operating Segment [Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	40,910	30,601	105,975	91,430
Operating Segment [Member] | Grow Tech [Member]
Revenue by Segment [Abstract]
Revenue		22	0	336	30
Intersegment Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 10,900	$ 7,100	$ 24,200	$ 19,500
[1]	The Manufacturing segment had $10.9 million and $7.1 million of intersegment revenue for the three months ended September 30, 2020 and 2019, respectively, and $24.2 million and $19.5 million for the nine months ended September 30, 2020 and 2019, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Contribution [Abstract]
Operating income	$ 74,228	$ 69,892	$ 168,867	$ 212,747
Other income (expense)	525	(4,979)	(4,068)	(11,153)
Income before provision for income taxes	74,753	64,913	164,799	201,594
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	162,267	132,961	404,845	412,148
Operating Segment [Member] | Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	160,840	134,206	407,504	414,583
Operating Segment [Member] | Mainland China [Member]
Segment Contribution [Abstract]
Operating income	54,522	48,619	135,577	158,873
Operating Segment [Member] | Americas/Pacific [Member]
Segment Contribution [Abstract]
Operating income	26,256	12,875	61,184	41,314
Operating Segment [Member] | South Korea [Member]
Segment Contribution [Abstract]
Operating income	25,232	24,770	73,421	76,417
Operating Segment [Member] | Southeast Asia [Member]
Segment Contribution [Abstract]
Operating income	20,426	22,063	54,121	60,895
Operating Segment [Member] | Japan [Member]
Segment Contribution [Abstract]
Operating income	18,245	16,287	49,292	46,216
Operating Segment [Member] | EMEA [Member]
Segment Contribution [Abstract]
Operating income	7,111	1,529	11,084	6,114
Operating Segment [Member] | Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	9,048	8,063	22,825	24,754
Operating Segment [Member] | Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	6,749	4,577	15,000	11,598
Operating Segment [Member] | Grow Tech [Member]
Segment Contribution [Abstract]
Operating income	(5,322)	(5,822)	(17,659)	(14,033)
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (88,039)	$ (63,069)	$ (235,978)	$ (199,401)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 17,920	$ 19,305	$ 55,279	$ 57,964
Capital expenditures	20,118	23,570	48,810	52,784
Operating Segments [Member] | Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	5,208	6,223	16,657	20,259
Capital expenditures	12,761	12,445	20,431	19,052
Operating Segments [Member] | Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	2,649	2,708	7,631	8,733
Capital expenditures	9,000	10,614	12,577	13,328
Operating Segments [Member] | Americas/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	268	213	766	633
Capital expenditures	125	337	891	1,084
Operating Segments [Member] | South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	756	1,115	2,731	3,997
Capital expenditures	173	972	537	1,051
Operating Segments [Member] | Southeast Asia [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	317	434	1,248	1,373
Capital expenditures	1,254	140	1,893	459
Operating Segments [Member] | Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	296	938	1,602	2,943
Capital expenditures	1,484	267	3,132	1,385
Operating Segments [Member] | EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	231	268	731	980
Capital expenditures	718	16	1,378	92
Operating Segments [Member] | Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	691	547	1,948	1,600
Capital expenditures	7	99	23	1,653
Operating Segments [Member] | Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	2,077	1,711	5,954	4,916
Capital expenditures	2,113	1,100	13,221	4,281
Operating Segments [Member] | Grow Tech [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,302	1,244	3,775	3,064
Capital expenditures	343	2,577	760	7,628
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	9,333	10,127	28,893	29,725
Capital expenditures	$ 4,901	$ 7,448	$ 14,398	$ 21,823

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Dec. 31, 2019
Restructuring [Abstract]
Non-cash impairment charges					$ 48,600
Cash charges associated with restructuring					22,100
Employee severance					20,100
Other related restructuring charges					2,000
Restructuring Reserve [Roll Forward]
Beginning balance			$ 15,462		$ 15,462
Amounts paid			(15,046)
Adjustments			(416)
Ending balance			$ 0
Restructuring activity	$ 0	$ 0		$ 0